12:00 AM
 | 
Dec 03, 2012
 |  BC Week In Review  |  Company News  |  Other News

Elan, J&J, Pfizer neurology news

The U.S. Securities and Exchange Commission (SEC) filed civil charges against Sidney Gilman, a neurology professor at the University of Michigan Medical School, alleging insider trading related to discontinued Alzheimer's disease product bapineuzumab. The agency also charged hedge fund CR Intrinsic Investors LLC and Mathew Martoma, a former portfolio manager at CR Intrinsic. According to the suit, Gilman, who was chairman of a...

Read the full 304 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >